Emmeline C. Academia

Statistics

Publications

Citations

2.3K

H-Index

Active since

2013

Affiliations

Buck Institute for Research on Aging(Current)

Marin Community Foundation

Sanford Consortium for Regenerative Medicine

Beth Israel Deaconess Medical Center

University of Arkansas for Medical Sciences

Emmeline C. Academia is an author at Buck Institute for Research on Aging specializing in life sciences, mammalian target of rapamycin signaling, and molecular biology.

ORCID

Publications per year

2013–2024

Publications

Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse

Marco Demaria, Monique N. O’Leary, Jianhui Chang et al. · Cancer Discovery · 2016 · 1.3K citations · Full text

Medicine, Cancer Biology, Cancer Pharmacology +15

Late-life rapamycin treatment reverses age-related heart dysfunction

James M. Flynn, Monique N. O’Leary, Christopher Zambataro et al. · Aging Cell · 2013 · 320 citations · Full text

Education, Pharmacology, Physiology +17

Rapamycin‐mediated <scp>mTORC</scp> 2 inhibition is determined by the relative expression of <scp>FK</scp> 506‐binding proteins

Katherine H. Schreiber, Denise Ortiz, Emmeline C. Academia et al. · Aging Cell · 2015 · 175 citations · Full text

Life Sciences, Oncology, Pharmacology +12

The Ribosomal Protein Rpl22 Controls Ribosome Composition by Directly Repressing Expression of Its Own Paralog, Rpl22l1

Monique N. O’Leary, Katherine H. Schreiber, Yong Zhang et al. · PLoS Genetics · 2013 · 140 citations · Full text

Life Sciences, Genetics, Molecular Biology +12

Muscle-specific 4E-BP1 signaling activation improves metabolic parameters during aging and obesity

Shih‐Yin Tsai, Joanna M. Sitzmann, Somasish Ghosh Dastidar et al. · Journal of Clinical Investigation · 2015 · 122 citations · Full text

Life Sciences, Molecular Biology, Physiology +17

1–5 of 13